Literature DB >> 23609531

Inhibition of atherosclerosis by angiotensin II type 1 receptor antagonists.

Stefan Peters1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23609531     DOI： 10.1007/s40256-013-0017-4

Source DB:  PubMed          Journal:  Am J Cardiovasc Drugs        ISSN： 1175-3277            Impact factor:   3.571


× No keyword cloud information.
  3 in total

1.  Effects of angiotensin receptor blockers on neointimal characteristics in angina patients requiring stent implantation: optical coherence tomography analysis.

Authors:  Jae Young Cho; Soon Jun Hong; Do-Sun Lim
Journal:  BMC Cardiovasc Disord       Date:  2017-11-15       Impact factor: 2.298

2.  Valsartan ameliorates ageing-induced aorta degeneration via angiotensin II type 1 receptor-mediated ERK activity.

Authors:  HaiYan Shan; Siyang Zhang; Xuelian Li; Kai Yu; Xin Zhao; Xinyue Chen; Bo Jin; XiaoJuan Bai
Journal:  J Cell Mol Med       Date:  2014-02-18       Impact factor: 5.310

3.  Effects of Valsartan on Restenosis in Patients with Arteriosclerosis Obliterans of the Lower Extremities Undergoing Interventional Therapy: A Prospective, Randomized, Single-Blind Trial.

Authors:  Wei Yao; Lixin Wang; Qing Chen; Fang Wang; Nana Feng
Journal:  Med Sci Monit       Date:  2020-06-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.